Fig. 5.
PARPi olaparib (AZD2281) was used at 25 μM for 3 days on HTLV-I-transformed MT-4, C91PL and MT-2 cells and apoptosis was measured by annexin V staining and FACS
PARPi olaparib (AZD2281) was used at 25 μM for 3 days on HTLV-I-transformed MT-4, C91PL and MT-2 cells and apoptosis was measured by annexin V staining and FACS